On the other hand, using a primary HCC cell line isolated from an AKT/Ras tumor, we showed that silencing of SCD1 triggers the (presumably) compensatory upregulation of SCD2, which might confer survival advantages to SCD1-deprived cells. This evidence concerns the gene AKT1 and neoplasm.